Homoeopathic treatment of neck pain

Repertorial approach of pain management in cervical radiculopathy in adults by using individualized homoeopathic medicines: Double-blind, randomized, placebo-controlled trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050202

Enrollment

117

Registered

2023-03-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M541- Radiculopathy

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies plus concomitant care: Intervention is planned as administering the indicated homeopathic medicines in centesimal potencies

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

dosage and repetition will be decided depending upon the individual requirement of the cases. All sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm. All the enrolle

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from cervical radiculopathy (ICD10 CM code M54.12) for 3 months or more who shows Spurlingâ??s test positive and Bakodyâ??s sign or positive shoulder abduction test. 2. Age between 18 and 65 years 3. Participants of either sex or transgender 4. Literate participants, ability to read and write in English, Bengali and/or Hindi. Illiterate participants will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires. 5. Providing with written informed consent voluntarily

Exclusion criteria

Exclusion criteria: 1. Cases with complications such as incomplete neurological recoveries, disc prolapse, disc herniation. 2. Patients with the history of taking spinal steroid injection within 6 months. 3. Patients on regular NSAIDS therapy. 4. Patients with uncontrolled diabetes mellitus, uncontrolled hypertension, or uncontrolled cardiovascular disease. 5. Vulnerable population - unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, institutionalized subjects, mentally incompetent people. 6. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 7. Pregnant and puerperal women, lactating mothers. 8. Patients with a habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 9. Self-reported immune-compromised states. 10. Already undergoing homoeopathic treatment for chronic disease within last 6 months. 11. Simultaneous participation in any other clinical trials

Design outcomes

Secondary

Measure	Time frame
McGill Pain Questionnaire Short FormTimepoint: Baseline, month 1, month 2;Neck disability indexTimepoint: Baseline, month 1, month 2	—

Primary

Measure	Time frame
0-10 numeric rating scale measuring intensity of painTimepoint: Baseline, month 1, month 2	—

Countries

India

Contacts

Public ContactRajat Kumar Pal

D N De Homoeopathic Medical College and Hospital

drrajatkumarpal@gmail.com9433130996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026